Clinical Trial Update: Protein Supplementation in Dialysis Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating protein supplementation in patients with end-stage renal disease sponsored by Vanderbilt University has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• protein supplementation (protein supplement)

Snippet

Sponsor: Vanderbilt University | Conditions: End Stage Renal Disease | Phase 2 | Status: TERMINATED